ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-PD-1 Antibody Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-14R7380
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Anti PD 1 Antibody Market Insights Forecast to 2028
BUY CHAPTERS

Global Anti-PD-1 Antibody Market Insights, Forecast to 2030

Code: QYRE-Auto-14R7380
Report
December 2024
Pages:110
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Bio X Cell
Thermo Fisher
InvivoGen
BioVision
Abcam
Bristol-Myers Squibb(BMS)
Merck
Ono Pharmaceutical Co Ltd
Lilly
Chugai Pharmaceutical Co., Ltd.
BeiGene Ltd
AbbVie
TG Therapeutics Inc
Novartis
Arcus Biosciences
Sino Biological Inc
3SBio Inc

Anti-PD-1 Antibody Market

Anti-PD-1 Antibody is used to inhibit PD-1 and its downstream signaling pathways.
The global Anti-PD-1 Antibody market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Anti-PD-1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Anti-PD-1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The Europe market for Anti-PD-1 Antibody is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The global key manufacturers of Anti-PD-1 Antibody include Bio X Cell, Thermo Fisher, InvivoGen, BioVision Inc, Abcam, Bristol-Myers Squibb (BMS), Merck, Ono Pharmaceutical Co., Ltd and Lilly, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Report Covers:
This report presents an overview of global market for Anti-PD-1 Antibody, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Anti-PD-1 Antibody, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Anti-PD-1 Antibody, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Anti-PD-1 Antibody sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Anti-PD-1 Antibody market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Anti-PD-1 Antibody sales, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Anti-PD-1 Antibody Market Report

Report Metric Details
Report Name Anti-PD-1 Antibody Market
Segment by Type
Segment by Application
Segment by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company InvivoGen, BioVision Inc, Abcam, Bristol-Myers Squibb (BMS), Merck, Ono Pharmaceutical Co., Ltd, Lilly, Chugai Pharmaceutical Co., Ltd, BeiGene, Abbvie, TG Therapeutics, Inc, Novartis, Arcus Biosciences, Sino Biological Inc, 3SBio Inc
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Anti-PD-1 Antibody in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 3: Detailed analysis of Anti-PD-1 Antibody manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Anti-PD-1 Antibody sales, revenue, price, gross margin, and recent development, etc.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-PD-1 Antibody Market report?

Ans: The main players in the Anti-PD-1 Antibody Market are InvivoGen, BioVision Inc, Abcam, Bristol-Myers Squibb (BMS), Merck, Ono Pharmaceutical Co., Ltd, Lilly, Chugai Pharmaceutical Co., Ltd, BeiGene, Abbvie, TG Therapeutics, Inc, Novartis, Arcus Biosciences, Sino Biological Inc, 3SBio Inc

What are the Application segmentation covered in the Anti-PD-1 Antibody Market report?

Ans: The Applications covered in the Anti-PD-1 Antibody Market report are IHC-P, ICC/IF, WB, Flow Cytometry, ELISA

What are the Type segmentation covered in the Anti-PD-1 Antibody Market report?

Ans: The Types covered in the Anti-PD-1 Antibody Market report are Monoclonal, Polyclonal

Recommended Reports

Antibody Drug Markets

Immune Checkpoint Inhibitors

Specific Antibody Markets

1 Study Coverage
1.1 Anti-PD-1 Antibody Product Introduction
1.2 Market by Type
1.2.1 Global Anti-PD-1 Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Monoclonal
1.2.3 Polyclonal
1.3 Market by Application
1.3.1 Global Anti-PD-1 Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 IHC-P
1.3.3 ICC/IF
1.3.4 WB
1.3.5 Flow Cytometry
1.3.6 ELISA
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Anti-PD-1 Antibody Sales Estimates and Forecasts 2019-2030
2.2 Global Anti-PD-1 Antibody Revenue by Region
2.2.1 Global Anti-PD-1 Antibody Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Anti-PD-1 Antibody Revenue by Region (2019-2024)
2.2.3 Global Anti-PD-1 Antibody Revenue by Region (2025-2030)
2.2.4 Global Anti-PD-1 Antibody Revenue Market Share by Region (2019-2030)
2.3 Global Anti-PD-1 Antibody Sales Estimates and Forecasts 2019-2030
2.4 Global Anti-PD-1 Antibody Sales by Region
2.4.1 Global Anti-PD-1 Antibody Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Anti-PD-1 Antibody Sales by Region (2019-2024)
2.4.3 Global Anti-PD-1 Antibody Sales by Region (2025-2030)
2.4.4 Global Anti-PD-1 Antibody Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Anti-PD-1 Antibody Sales by Manufacturers
3.1.1 Global Anti-PD-1 Antibody Sales by Manufacturers (2019-2024)
3.1.2 Global Anti-PD-1 Antibody Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-PD-1 Antibody in 2023
3.2 Global Anti-PD-1 Antibody Revenue by Manufacturers
3.2.1 Global Anti-PD-1 Antibody Revenue by Manufacturers (2019-2024)
3.2.2 Global Anti-PD-1 Antibody Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Anti-PD-1 Antibody Revenue in 2023
3.3 Global Key Players of Anti-PD-1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
3.4 Global Anti-PD-1 Antibody Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Anti-PD-1 Antibody, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Anti-PD-1 Antibody, Product Offered and Application
3.8 Global Key Manufacturers of Anti-PD-1 Antibody, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Anti-PD-1 Antibody Sales by Type
4.1.1 Global Anti-PD-1 Antibody Historical Sales by Type (2019-2024)
4.1.2 Global Anti-PD-1 Antibody Forecasted Sales by Type (2025-2030)
4.1.3 Global Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
4.2 Global Anti-PD-1 Antibody Revenue by Type
4.2.1 Global Anti-PD-1 Antibody Historical Revenue by Type (2019-2024)
4.2.2 Global Anti-PD-1 Antibody Forecasted Revenue by Type (2025-2030)
4.2.3 Global Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
4.3 Global Anti-PD-1 Antibody Price by Type
4.3.1 Global Anti-PD-1 Antibody Price by Type (2019-2024)
4.3.2 Global Anti-PD-1 Antibody Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Anti-PD-1 Antibody Sales by Application
5.1.1 Global Anti-PD-1 Antibody Historical Sales by Application (2019-2024)
5.1.2 Global Anti-PD-1 Antibody Forecasted Sales by Application (2025-2030)
5.1.3 Global Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
5.2 Global Anti-PD-1 Antibody Revenue by Application
5.2.1 Global Anti-PD-1 Antibody Historical Revenue by Application (2019-2024)
5.2.2 Global Anti-PD-1 Antibody Forecasted Revenue by Application (2025-2030)
5.2.3 Global Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
5.3 Global Anti-PD-1 Antibody Price by Application
5.3.1 Global Anti-PD-1 Antibody Price by Application (2019-2024)
5.3.2 Global Anti-PD-1 Antibody Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Anti-PD-1 Antibody Market Size by Type
6.1.1 US & Canada Anti-PD-1 Antibody Sales by Type (2019-2030)
6.1.2 US & Canada Anti-PD-1 Antibody Revenue by Type (2019-2030)
6.2 US & Canada Anti-PD-1 Antibody Market Size by Application
6.2.1 US & Canada Anti-PD-1 Antibody Sales by Application (2019-2030)
6.2.2 US & Canada Anti-PD-1 Antibody Revenue by Application (2019-2030)
6.3 US & Canada Anti-PD-1 Antibody Market Size by Country
6.3.1 US & Canada Anti-PD-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Anti-PD-1 Antibody Sales by Country (2019-2030)
6.3.3 US & Canada Anti-PD-1 Antibody Revenue by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Anti-PD-1 Antibody Market Size by Type
7.1.1 Europe Anti-PD-1 Antibody Sales by Type (2019-2030)
7.1.2 Europe Anti-PD-1 Antibody Revenue by Type (2019-2030)
7.2 Europe Anti-PD-1 Antibody Market Size by Application
7.2.1 Europe Anti-PD-1 Antibody Sales by Application (2019-2030)
7.2.2 Europe Anti-PD-1 Antibody Revenue by Application (2019-2030)
7.3 Europe Anti-PD-1 Antibody Market Size by Country
7.3.1 Europe Anti-PD-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Anti-PD-1 Antibody Sales by Country (2019-2030)
7.3.3 Europe Anti-PD-1 Antibody Revenue by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Anti-PD-1 Antibody Market Size
8.1.1 China Anti-PD-1 Antibody Sales (2019-2030)
8.1.2 China Anti-PD-1 Antibody Revenue (2019-2030)
8.2 China Anti-PD-1 Antibody Market Size by Application
8.2.1 China Anti-PD-1 Antibody Sales by Application (2019-2030)
8.2.2 China Anti-PD-1 Antibody Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Anti-PD-1 Antibody Market Size by Type
9.1.1 Asia Anti-PD-1 Antibody Sales by Type (2019-2030)
9.1.2 Asia Anti-PD-1 Antibody Revenue by Type (2019-2030)
9.2 Asia Anti-PD-1 Antibody Market Size by Application
9.2.1 Asia Anti-PD-1 Antibody Sales by Application (2019-2030)
9.2.2 Asia Anti-PD-1 Antibody Revenue by Application (2019-2030)
9.3 Asia Anti-PD-1 Antibody Sales by Region
9.3.1 Asia Anti-PD-1 Antibody Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Anti-PD-1 Antibody Revenue by Region (2019-2030)
9.3.3 Asia Anti-PD-1 Antibody Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Anti-PD-1 Antibody Market Size by Type
10.1.1 Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Anti-PD-1 Antibody Market Size by Application
10.2.1 Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Country
10.3.1 Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Bio X Cell
11.1.1 Bio X Cell Company Information
11.1.2 Bio X Cell Overview
11.1.3 Bio X Cell Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Bio X Cell Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bio X Cell Recent Developments
11.2 Thermo Fisher
11.2.1 Thermo Fisher Company Information
11.2.2 Thermo Fisher Overview
11.2.3 Thermo Fisher Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Thermo Fisher Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Thermo Fisher Recent Developments
11.3 InvivoGen
11.3.1 InvivoGen Company Information
11.3.2 InvivoGen Overview
11.3.3 InvivoGen Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 InvivoGen Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 InvivoGen Recent Developments
11.4 BioVision Inc
11.4.1 BioVision Inc Company Information
11.4.2 BioVision Inc Overview
11.4.3 BioVision Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 BioVision Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BioVision Inc Recent Developments
11.5 Abcam
11.5.1 Abcam Company Information
11.5.2 Abcam Overview
11.5.3 Abcam Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Abcam Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Abcam Recent Developments
11.6 Bristol-Myers Squibb (BMS)
11.6.1 Bristol-Myers Squibb (BMS) Company Information
11.6.2 Bristol-Myers Squibb (BMS) Overview
11.6.3 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Bristol-Myers Squibb (BMS) Recent Developments
11.7 Merck
11.7.1 Merck Company Information
11.7.2 Merck Overview
11.7.3 Merck Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Merck Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Merck Recent Developments
11.8 Ono Pharmaceutical Co., Ltd
11.8.1 Ono Pharmaceutical Co., Ltd Company Information
11.8.2 Ono Pharmaceutical Co., Ltd Overview
11.8.3 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Ono Pharmaceutical Co., Ltd Recent Developments
11.9 Lilly
11.9.1 Lilly Company Information
11.9.2 Lilly Overview
11.9.3 Lilly Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Lilly Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Lilly Recent Developments
11.10 Chugai Pharmaceutical Co., Ltd
11.10.1 Chugai Pharmaceutical Co., Ltd Company Information
11.10.2 Chugai Pharmaceutical Co., Ltd Overview
11.10.3 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Chugai Pharmaceutical Co., Ltd Recent Developments
11.11 BeiGene
11.11.1 BeiGene Company Information
11.11.2 BeiGene Overview
11.11.3 BeiGene Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.11.4 BeiGene Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 BeiGene Recent Developments
11.12 Abbvie
11.12.1 Abbvie Company Information
11.12.2 Abbvie Overview
11.12.3 Abbvie Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.12.4 Abbvie Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Abbvie Recent Developments
11.13 TG Therapeutics, Inc
11.13.1 TG Therapeutics, Inc Company Information
11.13.2 TG Therapeutics, Inc Overview
11.13.3 TG Therapeutics, Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.13.4 TG Therapeutics, Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 TG Therapeutics, Inc Recent Developments
11.14 Novartis
11.14.1 Novartis Company Information
11.14.2 Novartis Overview
11.14.3 Novartis Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.14.4 Novartis Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Novartis Recent Developments
11.15 Arcus Biosciences
11.15.1 Arcus Biosciences Company Information
11.15.2 Arcus Biosciences Overview
11.15.3 Arcus Biosciences Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.15.4 Arcus Biosciences Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Arcus Biosciences Recent Developments
11.16 Sino Biological Inc
11.16.1 Sino Biological Inc Company Information
11.16.2 Sino Biological Inc Overview
11.16.3 Sino Biological Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.16.4 Sino Biological Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.16.5 Sino Biological Inc Recent Developments
11.17 3SBio Inc
11.17.1 3SBio Inc Company Information
11.17.2 3SBio Inc Overview
11.17.3 3SBio Inc Anti-PD-1 Antibody Sales, Price, Revenue and Gross Margin (2019-2024)
11.17.4 3SBio Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
11.17.5 3SBio Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Anti-PD-1 Antibody Industry Chain Analysis
12.2 Anti-PD-1 Antibody Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Anti-PD-1 Antibody Production Mode & Process
12.4 Anti-PD-1 Antibody Sales and Marketing
12.4.1 Anti-PD-1 Antibody Sales Channels
12.4.2 Anti-PD-1 Antibody Distributors
12.5 Anti-PD-1 Antibody Customers
13 Market Dynamics
13.1 Anti-PD-1 Antibody Industry Trends
13.2 Anti-PD-1 Antibody Market Drivers
13.3 Anti-PD-1 Antibody Market Challenges
13.4 Anti-PD-1 Antibody Market Restraints
14 Key Findings in The Global Anti-PD-1 Antibody Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
FEATURED COMPANIES
Bio X Cell
Thermo Fisher
InvivoGen
BioVision
Abcam
Bristol-Myers Squibb(BMS)
Merck
Ono Pharmaceutical Co Ltd
Lilly
Chugai Pharmaceutical Co., Ltd.
BeiGene Ltd
AbbVie
TG Therapeutics Inc
Novartis
Arcus Biosciences
Sino Biological Inc
3SBio Inc
List of Tables
    Table 1. Global Anti-PD-1 Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Monoclonal
    Table 3. Major Manufacturers of Polyclonal
    Table 4. Global Anti-PD-1 Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 5. Global Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 6. Global Anti-PD-1 Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 7. Global Anti-PD-1 Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 8. Global Anti-PD-1 Antibody Revenue Market Share by Region (2019-2024)
    Table 9. Global Anti-PD-1 Antibody Revenue Market Share by Region (2025-2030)
    Table 10. Global Anti-PD-1 Antibody Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Anti-PD-1 Antibody Sales by Region (2019-2024) & (Kg)
    Table 12. Global Anti-PD-1 Antibody Sales by Region (2025-2030) & (Kg)
    Table 13. Global Anti-PD-1 Antibody Sales Market Share by Region (2019-2024)
    Table 14. Global Anti-PD-1 Antibody Sales Market Share by Region (2025-2030)
    Table 15. Global Anti-PD-1 Antibody Sales by Manufacturers (2019-2024) & (Kg)
    Table 16. Global Anti-PD-1 Antibody Sales Share by Manufacturers (2019-2024)
    Table 17. Global Anti-PD-1 Antibody Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 18. Global Anti-PD-1 Antibody Revenue Share by Manufacturers (2019-2024)
    Table 19. Global Key Players of Anti-PD-1 Antibody, Industry Ranking, 2022 VS 2023 VS 2024
    Table 20. Anti-PD-1 Antibody Price by Manufacturers 2019-2024 (USD/g)
    Table 21. Global Anti-PD-1 Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Anti-PD-1 Antibody by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-PD-1 Antibody as of 2023)
    Table 23. Global Key Manufacturers of Anti-PD-1 Antibody, Manufacturing Base Distribution and Headquarters
    Table 24. Global Key Manufacturers of Anti-PD-1 Antibody, Product Offered and Application
    Table 25. Global Key Manufacturers of Anti-PD-1 Antibody, Date of Enter into This Industry
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Anti-PD-1 Antibody Sales by Type (2019-2024) & (Kg)
    Table 28. Global Anti-PD-1 Antibody Sales by Type (2025-2030) & (Kg)
    Table 29. Global Anti-PD-1 Antibody Sales Share by Type (2019-2024)
    Table 30. Global Anti-PD-1 Antibody Sales Share by Type (2025-2030)
    Table 31. Global Anti-PD-1 Antibody Revenue by Type (2019-2024) & (US$ Million)
    Table 32. Global Anti-PD-1 Antibody Revenue by Type (2025-2030) & (US$ Million)
    Table 33. Global Anti-PD-1 Antibody Revenue Share by Type (2019-2024)
    Table 34. Global Anti-PD-1 Antibody Revenue Share by Type (2025-2030)
    Table 35. Anti-PD-1 Antibody Price by Type (2019-2024) & (USD/g)
    Table 36. Global Anti-PD-1 Antibody Price Forecast by Type (2025-2030) & (USD/g)
    Table 37. Global Anti-PD-1 Antibody Sales by Application (2019-2024) & (Kg)
    Table 38. Global Anti-PD-1 Antibody Sales by Application (2025-2030) & (Kg)
    Table 39. Global Anti-PD-1 Antibody Sales Share by Application (2019-2024)
    Table 40. Global Anti-PD-1 Antibody Sales Share by Application (2025-2030)
    Table 41. Global Anti-PD-1 Antibody Revenue by Application (2019-2024) & (US$ Million)
    Table 42. Global Anti-PD-1 Antibody Revenue by Application (2025-2030) & (US$ Million)
    Table 43. Global Anti-PD-1 Antibody Revenue Share by Application (2019-2024)
    Table 44. Global Anti-PD-1 Antibody Revenue Share by Application (2025-2030)
    Table 45. Anti-PD-1 Antibody Price by Application (2019-2024) & (USD/g)
    Table 46. Global Anti-PD-1 Antibody Price Forecast by Application (2025-2030) & (USD/g)
    Table 47. US & Canada Anti-PD-1 Antibody Sales by Type (2019-2024) & (Kg)
    Table 48. US & Canada Anti-PD-1 Antibody Sales by Type (2025-2030) & (Kg)
    Table 49. US & Canada Anti-PD-1 Antibody Revenue by Type (2019-2024) & (US$ Million)
    Table 50. US & Canada Anti-PD-1 Antibody Revenue by Type (2025-2030) & (US$ Million)
    Table 51. US & Canada Anti-PD-1 Antibody Sales by Application (2019-2024) & (Kg)
    Table 52. US & Canada Anti-PD-1 Antibody Sales by Application (2025-2030) & (Kg)
    Table 53. US & Canada Anti-PD-1 Antibody Revenue by Application (2019-2024) & (US$ Million)
    Table 54. US & Canada Anti-PD-1 Antibody Revenue by Application (2025-2030) & (US$ Million)
    Table 55. US & Canada Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 56. US & Canada Anti-PD-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 57. US & Canada Anti-PD-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 58. US & Canada Anti-PD-1 Antibody Sales by Country (2019-2024) & (Kg)
    Table 59. US & Canada Anti-PD-1 Antibody Sales by Country (2025-2030) & (Kg)
    Table 60. Europe Anti-PD-1 Antibody Sales by Type (2019-2024) & (Kg)
    Table 61. Europe Anti-PD-1 Antibody Sales by Type (2025-2030) & (Kg)
    Table 62. Europe Anti-PD-1 Antibody Revenue by Type (2019-2024) & (US$ Million)
    Table 63. Europe Anti-PD-1 Antibody Revenue by Type (2025-2030) & (US$ Million)
    Table 64. Europe Anti-PD-1 Antibody Sales by Application (2019-2024) & (Kg)
    Table 65. Europe Anti-PD-1 Antibody Sales by Application (2025-2030) & (Kg)
    Table 66. Europe Anti-PD-1 Antibody Revenue by Application (2019-2024) & (US$ Million)
    Table 67. Europe Anti-PD-1 Antibody Revenue by Application (2025-2030) & (US$ Million)
    Table 68. Europe Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 69. Europe Anti-PD-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 70. Europe Anti-PD-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 71. Europe Anti-PD-1 Antibody Sales by Country (2019-2024) & (Kg)
    Table 72. Europe Anti-PD-1 Antibody Sales by Country (2025-2030) & (Kg)
    Table 73. China Anti-PD-1 Antibody Sales by Type (2019-2024) & (Kg)
    Table 74. China Anti-PD-1 Antibody Sales by Type (2025-2030) & (Kg)
    Table 75. China Anti-PD-1 Antibody Revenue by Type (2019-2024) & (US$ Million)
    Table 76. China Anti-PD-1 Antibody Revenue by Type (2025-2030) & (US$ Million)
    Table 77. China Anti-PD-1 Antibody Sales by Application (2019-2024) & (Kg)
    Table 78. China Anti-PD-1 Antibody Sales by Application (2025-2030) & (Kg)
    Table 79. China Anti-PD-1 Antibody Revenue by Application (2019-2024) & (US$ Million)
    Table 80. China Anti-PD-1 Antibody Revenue by Application (2025-2030) & (US$ Million)
    Table 81. Asia Anti-PD-1 Antibody Sales by Type (2019-2024) & (Kg)
    Table 82. Asia Anti-PD-1 Antibody Sales by Type (2025-2030) & (Kg)
    Table 83. Asia Anti-PD-1 Antibody Revenue by Type (2019-2024) & (US$ Million)
    Table 84. Asia Anti-PD-1 Antibody Revenue by Type (2025-2030) & (US$ Million)
    Table 85. Asia Anti-PD-1 Antibody Sales by Application (2019-2024) & (Kg)
    Table 86. Asia Anti-PD-1 Antibody Sales by Application (2025-2030) & (Kg)
    Table 87. Asia Anti-PD-1 Antibody Revenue by Application (2019-2024) & (US$ Million)
    Table 88. Asia Anti-PD-1 Antibody Revenue by Application (2025-2030) & (US$ Million)
    Table 89. Asia Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 90. Asia Anti-PD-1 Antibody Revenue by Region (2019-2024) & (US$ Million)
    Table 91. Asia Anti-PD-1 Antibody Revenue by Region (2025-2030) & (US$ Million)
    Table 92. Asia Anti-PD-1 Antibody Sales by Region (2019-2024) & (Kg)
    Table 93. Asia Anti-PD-1 Antibody Sales by Region (2025-2030) & (Kg)
    Table 94. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Type (2019-2024) & (Kg)
    Table 95. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Type (2025-2030) & (Kg)
    Table 96. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Type (2019-2024) & (US$ Million)
    Table 97. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Type (2025-2030) & (US$ Million)
    Table 98. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Application (2019-2024) & (Kg)
    Table 99. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Application (2025-2030) & (Kg)
    Table 100. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Application (2019-2024) & (US$ Million)
    Table 101. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Application (2025-2030) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 103. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Country (2019-2024) & (US$ Million)
    Table 104. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue by Country (2025-2030) & (US$ Million)
    Table 105. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Country (2019-2024) & (Kg)
    Table 106. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales by Country (2025-2030) & (Kg)
    Table 107. Bio X Cell Company Information
    Table 108. Bio X Cell Description and Major Businesses
    Table 109. Bio X Cell Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 110. Bio X Cell Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Bio X Cell Recent Developments
    Table 112. Thermo Fisher Company Information
    Table 113. Thermo Fisher Description and Major Businesses
    Table 114. Thermo Fisher Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 115. Thermo Fisher Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Thermo Fisher Recent Developments
    Table 117. InvivoGen Company Information
    Table 118. InvivoGen Description and Major Businesses
    Table 119. InvivoGen Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 120. InvivoGen Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. InvivoGen Recent Developments
    Table 122. BioVision Inc Company Information
    Table 123. BioVision Inc Description and Major Businesses
    Table 124. BioVision Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 125. BioVision Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. BioVision Inc Recent Developments
    Table 127. Abcam Company Information
    Table 128. Abcam Description and Major Businesses
    Table 129. Abcam Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 130. Abcam Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Abcam Recent Developments
    Table 132. Bristol-Myers Squibb (BMS) Company Information
    Table 133. Bristol-Myers Squibb (BMS) Description and Major Businesses
    Table 134. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 135. Bristol-Myers Squibb (BMS) Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Bristol-Myers Squibb (BMS) Recent Developments
    Table 137. Merck Company Information
    Table 138. Merck Description and Major Businesses
    Table 139. Merck Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 140. Merck Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Merck Recent Developments
    Table 142. Ono Pharmaceutical Co., Ltd Company Information
    Table 143. Ono Pharmaceutical Co., Ltd Description and Major Businesses
    Table 144. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 145. Ono Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Ono Pharmaceutical Co., Ltd Recent Developments
    Table 147. Lilly Company Information
    Table 148. Lilly Description and Major Businesses
    Table 149. Lilly Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 150. Lilly Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Lilly Recent Developments
    Table 152. Chugai Pharmaceutical Co., Ltd Company Information
    Table 153. Chugai Pharmaceutical Co., Ltd Description and Major Businesses
    Table 154. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 155. Chugai Pharmaceutical Co., Ltd Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. Chugai Pharmaceutical Co., Ltd Recent Developments
    Table 157. BeiGene Company Information
    Table 158. BeiGene Description and Major Businesses
    Table 159. BeiGene Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 160. BeiGene Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. BeiGene Recent Developments
    Table 162. Abbvie Company Information
    Table 163. Abbvie Description and Major Businesses
    Table 164. Abbvie Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 165. Abbvie Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Abbvie Recent Developments
    Table 167. TG Therapeutics, Inc Company Information
    Table 168. TG Therapeutics, Inc Description and Major Businesses
    Table 169. TG Therapeutics, Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 170. TG Therapeutics, Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 171. TG Therapeutics, Inc Recent Developments
    Table 172. Novartis Company Information
    Table 173. Novartis Description and Major Businesses
    Table 174. Novartis Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 175. Novartis Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 176. Novartis Recent Developments
    Table 177. Arcus Biosciences Company Information
    Table 178. Arcus Biosciences Description and Major Businesses
    Table 179. Arcus Biosciences Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 180. Arcus Biosciences Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 181. Arcus Biosciences Recent Developments
    Table 182. Sino Biological Inc Company Information
    Table 183. Sino Biological Inc Description and Major Businesses
    Table 184. Sino Biological Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 185. Sino Biological Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 186. Sino Biological Inc Recent Developments
    Table 187. 3SBio Inc Company Information
    Table 188. 3SBio Inc Description and Major Businesses
    Table 189. 3SBio Inc Anti-PD-1 Antibody Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
    Table 190. 3SBio Inc Anti-PD-1 Antibody Product Model Numbers, Pictures, Descriptions and Specifications
    Table 191. 3SBio Inc Recent Developments
    Table 192. Key Raw Materials Lists
    Table 193. Raw Materials Key Suppliers Lists
    Table 194. Anti-PD-1 Antibody Distributors List
    Table 195. Anti-PD-1 Antibody Customers List
    Table 196. Anti-PD-1 Antibody Market Trends
    Table 197. Anti-PD-1 Antibody Market Drivers
    Table 198. Anti-PD-1 Antibody Market Challenges
    Table 199. Anti-PD-1 Antibody Market Restraints
    Table 200. Research Programs/Design for This Report
    Table 201. Key Data Information from Secondary Sources
    Table 202. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-PD-1 Antibody Product Picture
    Figure 2. Global Anti-PD-1 Antibody Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Anti-PD-1 Antibody Market Share by Type in 2023 & 2030
    Figure 4. Monoclonal Product Picture
    Figure 5. Polyclonal Product Picture
    Figure 6. Global Anti-PD-1 Antibody Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 7. Global Anti-PD-1 Antibody Market Share by Application in 2023 & 2030
    Figure 8. IHC-P
    Figure 9. ICC/IF
    Figure 10. WB
    Figure 11. Flow Cytometry
    Figure 12. ELISA
    Figure 13. Anti-PD-1 Antibody Report Years Considered
    Figure 14. Global Anti-PD-1 Antibody Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 15. Global Anti-PD-1 Antibody Revenue 2019-2030 (US$ Million)
    Figure 16. Global Anti-PD-1 Antibody Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 17. Global Anti-PD-1 Antibody Revenue Market Share by Region (2019-2030)
    Figure 18. Global Anti-PD-1 Antibody Sales 2019-2030 ((Kg)
    Figure 19. Global Anti-PD-1 Antibody Sales Market Share by Region (2019-2030)
    Figure 20. US & Canada Anti-PD-1 Antibody Sales YoY (2019-2030) & (Kg)
    Figure 21. US & Canada Anti-PD-1 Antibody Revenue YoY (2019-2030) & (US$ Million)
    Figure 22. Europe Anti-PD-1 Antibody Sales YoY (2019-2030) & (Kg)
    Figure 23. Europe Anti-PD-1 Antibody Revenue YoY (2019-2030) & (US$ Million)
    Figure 24. China Anti-PD-1 Antibody Sales YoY (2019-2030) & (Kg)
    Figure 25. China Anti-PD-1 Antibody Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Asia (excluding China) Anti-PD-1 Antibody Sales YoY (2019-2030) & (Kg)
    Figure 27. Asia (excluding China) Anti-PD-1 Antibody Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales YoY (2019-2030) & (Kg)
    Figure 29. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. The Anti-PD-1 Antibody Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 31. The Top 5 and 10 Largest Manufacturers of Anti-PD-1 Antibody in the World: Market Share by Anti-PD-1 Antibody Revenue in 2023
    Figure 32. Global Anti-PD-1 Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 33. Global Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
    Figure 34. Global Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
    Figure 35. Global Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
    Figure 36. Global Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
    Figure 37. US & Canada Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
    Figure 38. US & Canada Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
    Figure 39. US & Canada Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
    Figure 40. US & Canada Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Anti-PD-1 Antibody Revenue Share by Country (2019-2030)
    Figure 42. US & Canada Anti-PD-1 Antibody Sales Share by Country (2019-2030)
    Figure 43. U.S. Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 44. Canada Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 45. Europe Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
    Figure 46. Europe Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
    Figure 47. Europe Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
    Figure 48. Europe Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
    Figure 49. Europe Anti-PD-1 Antibody Revenue Share by Country (2019-2030)
    Figure 50. Europe Anti-PD-1 Antibody Sales Share by Country (2019-2030)
    Figure 51. Germany Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 52. France Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 53. U.K. Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 54. Italy Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 55. Russia Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 56. China Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
    Figure 57. China Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
    Figure 58. China Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
    Figure 59. China Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
    Figure 60. Asia Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
    Figure 61. Asia Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
    Figure 62. Asia Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
    Figure 63. Asia Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Anti-PD-1 Antibody Revenue Share by Region (2019-2030)
    Figure 65. Asia Anti-PD-1 Antibody Sales Share by Region (2019-2030)
    Figure 66. Japan Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 67. South Korea Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 68. China Taiwan Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 69. Southeast Asia Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 70. India Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 71. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales Market Share by Type (2019-2030)
    Figure 72. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue Market Share by Type (2019-2030)
    Figure 73. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales Market Share by Application (2019-2030)
    Figure 74. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue Market Share by Application (2019-2030)
    Figure 75. Middle East, Africa and Latin America Anti-PD-1 Antibody Revenue Share by Country (2019-2030)
    Figure 76. Middle East, Africa and Latin America Anti-PD-1 Antibody Sales Share by Country (2019-2030)
    Figure 77. Brazil Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 78. Mexico Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 79. Turkey Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 80. Israel Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 81. GCC Countries Anti-PD-1 Antibody Revenue (2019-2030) & (US$ Million)
    Figure 82. Anti-PD-1 Antibody Value Chain
    Figure 83. Anti-PD-1 Antibody Production Process
    Figure 84. Channels of Distribution
    Figure 85. Distributors Profiles
    Figure 86. Bottom-up and Top-down Approaches for This Report
    Figure 87. Data Triangulation
    Figure 88. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Global Anti PD 1 MAb Market Insights Forecast to 2030
Global PD 1 and PD L1 Antibody Market Insights Forecast to 2030
PD L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pd 1 and Pd L1 Inhibitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD 1 and PD L1 Immunotherapy Market Insights Forecast to 2030
Global PD 1 and PD L1 Monoclonal Antibody Market Research Report 2025
Global PD 1 and PDL 1 Inhibitors Market Research Report 2025
Global PD 1 Inhibitor Market Research Report 2024
PD 1 and PD L1 Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Checkpoint Inhibitors for Cancer Market Research Report 2024
Small Molecule Inhibitors for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Anti CD25 Monoclonal Antibody Market Research Report 2024
Global Small Molecule Antibodies Market Insights Forecast to 2030
Global PD 1 PD L1 Checkpoint Inhibitors Market Research Report 2024
Global Checkpoint Inhibitors for Treating Cancer Market Insights Forecast to 2030
Global Cancer Immunotherapies Market Insights Forecast to 2030
Global Anti CD20 Monoclonal Antibodies Market Research Report 2024
Global Therapeutic Monoclonal Antibodies Market Research Report 2024
Global Anti HMGB1 Antibody Market Research Report 2024
Global Immuno Oncology Treatment Market Insights Forecast to 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions